1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Enterome Bioscience SA - Product Pipeline Analysis, 2015 Update

Summary

Enterome Bioscience SA (Enterome) is an in-vitro diagnostic company. It develops medical tests, and companion diagnostics to improve the management of microbiome-related diseases such as metabolic, inflammatory bowel diseases, and central nervous system linked diseases. Enterome develops these tests based on its proprietary Metagenotyping technology, platform, which helps identify microbiome-based biomarkers and screen for microbiome-derived molecules. It intends to develop biomarkers into new diagnostic products for patient classification and forecasting treatment response. The company plans to develop microbiome-derived molecules as drug candidates or drug targets. Enterome’s product pipeline include MET 230 stratified nutrition testMET 220 bariatric surgery outcome predictionIBD 110 Crohn’s disease activity monitoring and IBD 120 ulcerative colitis relapse prediction. It works in partnership with private or public institutions, KOL in scientific and medical communities, medical food manufacturers and diagnostic companies. Enterome is headquartered in Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Enterome Bioscience SA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

Enterome Bioscience SA - Product Pipeline Analysis, 2015 Update
Table of Contents
Table of Contents 2
List of Tables 3
List of Figuress 4
Enterome Bioscience SA Company Snapshot 5
Enterome Bioscience SA Company Overview 5
Key Information 6
Enterome Bioscience SA Pipeline Products and Clinical Trials Overview 7
Enterome Bioscience SA - Pipeline Analysis Overview 9
Key Facts 9
Enterome Bioscience SA - Major Products and Services 10
Enterome Bioscience SA Pipeline Products by Development Stage 11
Enterome Bioscience SA Pipeline Products Overview 13
Biomarker Panel - Liver Cirrhosis 13
Biomarker Panel - Liver Cirrhosis Product Overview 13
EFL Test 14
EFL Test Product Overview 14
IBD 110 Crohn's Disease - Activity Monitoring 15
IBD 110 Crohn's Disease - Activity Monitoring Product Overview 15
IBD 120 Ulcerative Collitis Relapse Prediction Test 16
IBD 120 Ulcerative Collitis Relapse Prediction Test Product Overview 16
MET 220 Bariatric Surgery-Outcome Prediction Test 17
MET 220 Bariatric Surgery-Outcome Prediction Test Product Overview 17
MET 230 Stratified Nutrition Test 18
MET 230 Stratified Nutrition Test Product Overview 18
Enterome Bioscience SA - Key Competitors 19
Enterome Bioscience SA - Key Employees 20
Enterome Bioscience SA - Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Enterome Bioscience SA, Recent Developments 22
Mar 19, 2015: Oral Presentation and Poster at the IHMC congress in Luxembourg 22
Jun 17, 2014: Enterome to participate on panel at BIO2014 entitled: Microbiome Modulators: Opportunities and Challenges to Creating a New Drug Class 22
Apr 24, 2014: Enterome to Chair Panel at Forthcoming Microbiome / Microbiota RandD and Business Collaboration Forum in London, UK 22
Apr 22, 2014: Enterome appoints Prof. Alessandra Cervino as Head of Discovery 23
Dec 24, 2013: Enterome's shareholder, SEVENTURE PARTNERS, announced the launch of its new fund 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Enterome Bioscience SA, Key Facts 6
Enterome Bioscience SA Pipeline Products and Clinical Trials Overview 7
Enterome Bioscience SA Pipeline Products by Equipment Type 7
Enterome Bioscience SA Pipeline Products by Indication 8
Enterome Bioscience SA, Key Facts 9
Enterome Bioscience SA, Major Products and Services 10
Enterome Bioscience SA Number of Pipeline Products by Development Stage 11
Enterome Bioscience SA Pipeline Products Summary by Development Stage 12
Biomarker Panel - Liver Cirrhosis - Product Status 13
Biomarker Panel - Liver Cirrhosis - Product Description 13
EFL Test - Product Status 14
EFL Test - Product Description 14
IBD 110 Crohn's Disease - Activity Monitoring - Product Status 15
IBD 110 Crohn's Disease - Activity Monitoring - Product Description 15
IBD 120 Ulcerative Collitis Relapse Prediction Test - Product Status 16
IBD 120 Ulcerative Collitis Relapse Prediction Test - Product Description 16
MET 220 Bariatric Surgery-Outcome Prediction Test - Product Status 17
MET 220 Bariatric Surgery-Outcome Prediction Test - Product Description 17
MET 230 Stratified Nutrition Test - Product Status 18
MET 230 Stratified Nutrition Test - Product Description 18
Enterome Bioscience SA, Key Employees 20

List of Figuress
Enterome Bioscience SA Pipeline Products by Equipment Type 8
Enterome Bioscience SA Pipeline Products by Development Stage 11

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Probable ATP Dependent RNA Helicase DDX58 (DEAD Box Protein 58 or RIG I Like Receptor 1 or Retinoic Acid Inducible Gene 1 Protein or DDX58 or EC 3.6.4.13) - Pipeline Review, H2 2016

Probable ATP Dependent RNA Helicase DDX58 (DEAD Box Protein 58 or RIG I Like Receptor 1 or Retinoic Acid Inducible Gene 1 Protein or DDX58 or EC 3.6.4.13) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Probable ATP Dependent RNA Helicase DDX58 (DEAD Box Protein 58 or RIG I Like Receptor 1 or Retinoic Acid Inducible Gene 1 Protein or DDX58 or EC 3.6.4.13) - Pipeline Review, H2 2016 Summary Global Markets ...

Ileal Sodium/Bile Acid Cotransporter (Apical Sodium Dependent Bile Acid Transporter or ASBT or Sodium/Taurocholate Cotransporting Polypeptide Ileal or Solute Carrier Family 10 Member 2 or SLC10A2) - Pipeline Review, H2 2016

Ileal Sodium/Bile Acid Cotransporter (Apical Sodium Dependent Bile Acid Transporter or ASBT or Sodium/Taurocholate Cotransporting Polypeptide Ileal or Solute Carrier Family 10 Member 2 or SLC10A2) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Ileal Sodium/Bile Acid Cotransporter (Apical Sodium Dependent Bile Acid Transporter or ASBT or Sodium/Taurocholate Cotransporting Polypeptide Ileal or Solute Carrier Family 10 Member 2 or SLC10A2) - Pipeline ...

Caspase 7 (Apoptotic Protease Mch 3 or ICE Like Apoptotic Protease 3 or CMH 1 or CASP7 or EC 3.4.22.60) - Pipeline Review, H2 2016

Caspase 7 (Apoptotic Protease Mch 3 or ICE Like Apoptotic Protease 3 or CMH 1 or CASP7 or EC 3.4.22.60) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Caspase 7 (Apoptotic Protease Mch 3 or ICE Like Apoptotic Protease 3 or CMH 1 or CASP7 or EC 3.4.22.60) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Caspase 7 (Apoptotic Protease Mch ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.